Lancaster General Hospital   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Lancaster PA United States (1893)

Organization Overview

First Clinical Trial
2011
NCT01330589
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Lancaster General Health Sports Medicine | Lancaster General Hospital

Active Ingredients

Drugs in Phase 4 Trials (1)

nortriptyline (aventyl) (1 trial)

Drugs in Phase 3 Trials (2)

acetaminophen (tylenol) (1 trial)

tranexamic acid (cyklokapron) (1 trial)

Drugs in Other Trials (4)

hypericum perforatum (1 trial)

melatonin (1 trial)

peppermint extract (1 trial)

vitamin c (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Brain Concussion (Phase 4)

Brain Injuries (Phase 4)

Brain Injuries, Traumatic (Phase 4)

Fractures, Bone (Phase 3)

Headache (Phase 4)

Hip Fractures (Phase 3)

Post-Concussion Syndrome (Phase 4)

Post-Traumatic Headache (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 7